Literature DB >> 13199388

Phenylbutazone and renal function.

B M JOHNSON, I M LARKIN.   

Abstract

Entities:  

Keywords:  ANALGESICS/injurious effects; ANEMIA/etiology and pathogenesis; KIDNEYS/diseases; PURPURA/etiology and pathogenesis

Mesh：

Substances：

Year:  1954        PMID： 13199388      PMCID： PMC2079839          DOI： 10.1136/bmj.2.4896.1088

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Effect of butazolidine on the excretion of water and electrolytes.

Authors:  J GREEN; P O WILLIAMS
Journal:  Lancet       Date:  1953-03-21       Impact factor: 79.321

2.  Phenylbutazone (butazolidine) in the treatment of chronic arthritis.

Authors:  L CUDKOWICZ; J H JACOBS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

3.  Fatality due to agranulocytosis following use of phenylbutazone (butazolidin).

Authors:  A D ETESS; A S JACOBSON
Journal:  J Am Med Assoc       Date:  1953-02-21

4.  Agranulocytosis following use of phenylbutazone (butazolidin).

Authors:  E BERSHOF; A C OXMAN
Journal:  J Am Med Assoc       Date:  1953-02-14

5.  Agranulocytosis following administration of phenylbutazone (butazolidin).

Authors:  J L STIFEL; J C BURNHEIMER
Journal:  J Am Med Assoc       Date:  1953-02-14

6.  Agranulocytosis following use of phenylbutazone (butazolidin); report of a case.

Authors:  C HINZ; R W LAMONT-HAVERS; B COMINSKY; L M GAINES
Journal:  J Am Med Assoc       Date:  1953-01-03
  6 in total
  2 in total

1.  Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.

Authors:  J M MACCARTHY; R T JACKSON
Journal:  Br Med J       Date:  1955-07-23

2.  [Irgapyrine poisoning of a child with fatal outcome and special attention to changes in the electrocardiogram and toxicologic studies].

Authors:  K Ibe; K H Beyer; H Burmeister; K D Grosser
Journal:  Arch Toxikol       Date:  1967
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.